旺山旺水-B（02630）今日盘中大跌5.91%，引发市场关注。该公司昨日刚在香港联交所挂牌上市，首日股价飙升145.73%，收报82港元。
分析人士指出，今日的下跌很可能是对昨日暴涨的正常市场反应。新股上市后的第二个交易日出现回调是较为常见的现象，尤其是在首日出现如此大幅上涨之后。
旺山旺水是一家综合一体化创新小分子药物公司，总部位于苏州工业园区。公司主要致力于神经精神、生殖健康及病毒感染领域的新药创制。其核心产品包括用于治疗重度抑郁症的LV232和用于治疗男性勃起功能障碍的TPN171（商品名为昂伟达）。
投资者应密切关注旺山旺水未来几个交易日的表现，以观察其股价是否会趋于稳定。同时，公司的基本面、研发进展以及市场拓展情况也将是影响其长期股价走势的关键因素。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.